BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29113782)

  • 1. Interobserver variability in rectum contouring in high-dose-rate brachytherapy for prostate cancer: A multi-institutional prospective analysis.
    Chicas-Sett R; Celada-Alvarez F; Roldan S; Rodriguez-Villalba S; Santos-Olias M; Soler-Catalan P; Ibanez-Rosello B; Arribas L; Tormo A; Benlloch JM; Perez-Calatayud J
    Brachytherapy; 2018; 17(1):208-213. PubMed ID: 29113782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric consequences of interobserver variability in delineating the organs at risk in gynecologic interstitial brachytherapy.
    Damato AL; Townamchai K; Albert M; Bair RJ; Cormack RA; Jang J; Kovacs A; Lee LJ; Mak KS; Mirabeau-Beale KL; Mouw KW; Phillips JG; Pretz JL; Russo AL; Lewis JH; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):674-81. PubMed ID: 24803035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience.
    Chicas-Sett R; Celada-Alvarez F; Roldán S; Torregrosa A; Betancourt J; Bautista-Ballesteros J; Farga D; Ibañez B; Tormo A; Perez-Calatayud J
    J Contemp Brachytherapy; 2016 Aug; 8(4):349-55. PubMed ID: 27648090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deformable image registration for cervical cancer brachytherapy dose accumulation: Organ at risk dose-volume histogram parameter reproducibility and anatomic position stability.
    Flower E; Do V; Sykes J; Dempsey C; Holloway L; Summerhayes K; Thwaites DI
    Brachytherapy; 2017; 16(2):387-392. PubMed ID: 28161434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
    Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
    Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.
    Gruhl JD; Zheng D; Longo JL; Enke C; Wahl AO
    Brachytherapy; 2017; 16(2):373-377. PubMed ID: 28039010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: Evaluating deformably registered dose distribution addition using parameter-based addition.
    Moulton CR; House MJ; Lye V; Tang CI; Krawiec M; Joseph DJ; Denham JW; Ebert MA
    J Med Imaging Radiat Oncol; 2017 Aug; 61(4):534-542. PubMed ID: 28185419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose-rate brachytherapy boost for prostate cancer: Analysis of dose-volume histogram parameters for predicting late rectal toxicity.
    Chicas-Sett R; Farga D; Perez-Calatayud MJ; Celada F; Roldan S; Fornes-Ferrer V; Ibanez-Rosello B; Tormo A; Benlloch JM; Perez-Calatayud J
    Brachytherapy; 2017; 16(3):511-517. PubMed ID: 28366276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of
    Shukla AK; Jangid PK; Rajpurohit VS; Verma A; Dangayach SK; Gagrani V; Rathore NK
    J Cancer Res Ther; 2019; 15(6):1212-1215. PubMed ID: 31898649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder distension improves the dosimetry of organs at risk during intracavitary cervical high-dose-rate brachytherapy.
    Harmon G; Chinsky B; Surucu M; Harkenrider M; Small W
    Brachytherapy; 2016; 15(1):30-4. PubMed ID: 26521661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of delineation uncertainties on dose to organs at risk in CT-guided intracavitary brachytherapy.
    Duane FK; Langan B; Gillham C; Walsh L; Rangaswamy G; Lyons C; Dunne M; Walker C; McArdle O
    Brachytherapy; 2014; 13(2):210-8. PubMed ID: 24090973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy.
    Sabater S; Arenas M; Berenguer R; Machin-Hamalainen S; Andres I; Sevillano MM; Jimenez-Jimenez E; Martos A; Lopez-Honrubia V; Fernandez-Lopez J
    Brachytherapy; 2015; 14(4):458-63. PubMed ID: 25900391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of treatment planning techniques for low-dose-rate (LDR) prostate brachytherapy.
    Connolly D; Sands G; Winter H; Foley MJ; Kleefeld C
    Brachytherapy; 2021; 20(2):410-419. PubMed ID: 33234407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative ultrasound-based planning can effectively replace postoperative CT-based planning for high-dose-rate brachytherapy for prostate cancer.
    Batchelar DL; Chung HT; Loblaw A; Law N; Cisecki T; Morton GC
    Brachytherapy; 2016; 15(4):399-405. PubMed ID: 27180126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
    Peters M; Hoekstra CJ; van der Voort van Zyp JR; Westendorp H; van de Pol SM; Moerland MA; Maenhout M; Kattevilder R; van Vulpen M
    Brachytherapy; 2016; 15(1):85-93. PubMed ID: 26614233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of a rectal ultrasound probe on the separation between prostate and rectum in high-dose-rate brachytherapy.
    Rylander S; Buus S; Bentzen L; Pedersen EM; Tanderup K
    Brachytherapy; 2015; 14(5):711-7. PubMed ID: 26164752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy.
    Nicolae A; Murgic J; Kruljac I; Dubnitzky L; D'Alimonte L; Lu L; Cumal A; Law N; Morton G; Loblaw A; Chung HT; Ravi A
    Brachytherapy; 2018; 17(2):306-312. PubMed ID: 29239812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.